The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I am a molecular-cell biologist studying the genetic regulation of intestinal homeostasis in development and disease with the aim of identifying novel molecular targets for the treatment of disease and that can be validated in relevant preclinical mouse models.
I am a molecular-cell biologist determining the molecular regulation, cellular localisation and function of tumour suppressor proteins in cancer. We aim to elucidate pathways that can ultimately be targeted for intervention in breast and colon cancer.
I am a biochemist-cell biologist, working on the growth factors of the gastrointestinal tract. My discovery that the activity of non-amidated gastrins is dependent on ferric ions has opened several avenues for the development of new therapies for colorect
Receptor Tyrosine Kinase Function As Molecular Target In Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$415,788.00
Summary
As molecular cell biologist and protein chemist my motivation for research is to tackle metastatic cancer, one of the principle health burdens of the 21 century. Over the next five years I will lead R&D programs with national and international collaborators that will generate new diagnostic approaches and insights in basic and translational research. These will allow us to develop anti-cancer drugs, which target several of the mechanisms that are active in metastatic cancers.
I am a reproductive physiologist who collaborates with a number of leading Hospital, University and Institute Research Groups nationally and internationally examining the potential of genetically modified pigs as organ, tissue and cell donors for humans.